MediPharm Labs Announces Participation at Upcoming BMO & TMX Hemp & Medical Cannabis Conference in London, UK

1w
3m read
Summary

MediPharm Labs Announces Participation at Upcoming BMO & TMX Hemp & Medical Cannabis Conference in London, UK TORONTO, Oct. 07, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid isolation, is pleased to announce its participation at the BMO & TMX Hemp & Medical Cannabis Conference in London, UK on October 16, 2019. Pat McCutcheon, CEO of MediPharm Labs, will participate on a panel discussion that will provide an update on key medical cannabis markets in Europe. MediPharm Labs will be presenting alongside management representatives from Aurora Cannabis Inc. and Canopy Growth Corp. For more information: Laura Lepore, VP, Investor Relations Telephone: 705-719-7425 ext 216 Email: investors@medipharmlabs.com Website: www.medipharmlabs.com CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION: This news release contains “forward-looking information” and “forward-looking statements” (collectively, “forward-looking statements”) within the meaning of the applicable Canadian securities legislation.

Article Preview

TORONTO, Oct. 07, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid isolation, is pleased to announce its participation at the BMO & TMX Hemp & Medical Cannabis Conference in London, UK on October 16, 2019.

Pat McCutcheon, CEO of MediPharm Labs, will participate on a panel discussion that will provide an update on key medical cannabis markets in Europe.  MediPharm Labs will be presenting alongside management representatives from Aurora Cannabis Inc. and...

Read the full article @ Cannabis Law Report